Home
Data
Calendar
Blog
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 309.65 | 318.96 | 307.28 | NA | 159.69 | 154.89 | 152.11 | NA | 151.39 | 150.99 | 149.89 | NA | 149.29 | 151.99 | 151.22 | NA | 147.56 | 147.39 | 147.96 | NA | 130.73 | 128.02 | 127.69 | NA | 128.22 | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Shares Outstanding Basic | 309.65 | 309.12 | 307.28 | NA | 154.22 | 153.74 | 152.11 | NA | 151.39 | 150.99 | 149.89 | NA | 149.29 | 149.00 | 148.01 | NA | 147.56 | 147.39 | 147.18 | NA | 130.73 | 128.02 | 127.69 | NA | 127.25 | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Basic | 0.00 | 0.02 | -0.30 | -0.58 | 0.06 | 0.08 | -0.05 | -0.03 | -0.02 | -0.80 | -0.01 | -0.04 | -0.03 | 0.10 | 0.05 | -0.02 | -0.06 | -0.08 | 0.78 | -0.23 | -2.03 | -0.13 | -0.37 | -0.07 | 0.05 | -0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Per Share Diluted | 0.00 | 0.02 | -0.30 | -0.57 | 0.06 | 0.08 | -0.05 | -0.03 | -0.02 | -0.80 | -0.01 | -0.04 | -0.03 | 0.10 | 0.04 | -0.02 | -0.06 | -0.08 | 0.78 | -0.23 | -2.03 | -0.13 | -0.37 | -0.07 | 0.05 | -0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 702.47 | 701.78 | 659.19 | 616.98 | 620.04 | 599.05 | 557.54 | 609.76 | 545.56 | 559.36 | 497.63 | 536.90 | 528.59 | 535.08 | 493.11 | 510.03 | 519.29 | 464.66 | 498.53 | 397.33 | 378.28 | 404.64 | 446.12 | 497.53 | 476.49 | 413.79 | 275.19 | 293.37 | 254.73 | 259.87 | 225.68 | |
| Revenues | 702.47 | 701.78 | 659.19 | 616.98 | 620.04 | 599.05 | 557.54 | 609.76 | 545.56 | 559.36 | 497.63 | 536.90 | 528.59 | 535.08 | 493.11 | 510.03 | 519.29 | 464.66 | 498.53 | 397.33 | 378.28 | 404.64 | 446.12 | 497.53 | 476.49 | 413.79 | 275.19 | 293.37 | 254.73 | 259.87 | 225.68 | |
| Cost Of Goods And Services Sold | 432.91 | 451.83 | 421.13 | 427.15 | 387.51 | 379.02 | 379.35 | 389.05 | 350.65 | 353.72 | 323.06 | 348.49 | 329.39 | 322.58 | 301.54 | 342.96 | 353.35 | 319.67 | 313.58 | 273.37 | 267.72 | 296.38 | 309.74 | 304.12 | 276.38 | 235.49 | 130.59 | 141.95 | 119.72 | 136.14 | NA | |
| Gross Profit | 269.56 | 249.95 | 238.06 | 189.83 | 232.53 | 220.02 | 178.19 | 215.39 | 194.23 | 200.52 | 174.57 | 166.40 | 198.51 | 212.50 | 191.56 | 167.07 | 133.59 | 144.24 | 183.50 | 110.23 | 54.43 | 105.25 | 83.08 | 193.41 | 200.10 | 178.29 | 144.59 | 151.42 | 135.01 | 123.73 | 116.02 | |
| Research And Development Expense | 61.10 | 36.05 | 39.30 | 46.09 | 41.38 | 37.80 | 38.69 | 41.91 | 50.23 | 50.75 | 52.80 | 51.87 | 48.93 | 52.86 | 48.18 | 53.46 | 44.52 | 45.57 | 36.38 | 48.05 | 38.12 | 48.02 | 53.86 | 56.65 | 43.00 | 50.34 | 44.21 | 43.49 | 41.32 | 47.18 | NA | |
| Selling General And Administrative Expense | 118.69 | 116.46 | 112.59 | 109.00 | 113.01 | 105.57 | 102.10 | 102.16 | 100.07 | 98.81 | 98.67 | 97.22 | 91.40 | 86.16 | 90.73 | 84.69 | 83.12 | 80.94 | 77.98 | 74.08 | 63.80 | 67.28 | 84.44 | 74.24 | 78.08 | 53.00 | 25.12 | 26.97 | 27.44 | 26.94 | NA | |
| Operating Income Loss | 88.81 | 95.47 | -10.75 | 14.19 | 75.65 | 80.08 | 34.45 | 36.03 | 44.35 | -198.62 | 23.30 | 11.18 | 28.52 | 67.12 | 45.91 | 20.18 | 2.44 | 10.75 | 57.79 | -23.14 | -112.27 | -18.91 | -94.36 | 23.28 | 74.56 | -181.06 | 63.55 | 79.02 | 78.75 | 44.60 | NA | |
| Interest Paid Net | 66.37 | 72.03 | 64.51 | 56.21 | 47.90 | 47.64 | 41.07 | 50.51 | 34.89 | 30.03 | 27.29 | 30.07 | 30.24 | 31.52 | 29.92 | 30.98 | 30.77 | 33.05 | 35.39 | 36.70 | 40.77 | 41.07 | 40.03 | 42.43 | 38.68 | 31.55 | 18.84 | 17.12 | 17.68 | NA | NA | |
| Interest Income Expense Nonoperating Net | -65.51 | -65.72 | -65.70 | -59.55 | -50.91 | -50.86 | -49.31 | -47.03 | -42.39 | -35.62 | -33.34 | -33.96 | -34.40 | -34.08 | -33.88 | -34.53 | -34.90 | -36.67 | -39.90 | -38.83 | -42.21 | -43.89 | -43.28 | -42.88 | -43.02 | -36.62 | -21.05 | -19.96 | -19.22 | -17.73 | NA | |
| Income Tax Expense Benefit | 3.67 | 3.62 | 6.16 | 9.88 | -2.08 | -0.02 | 0.67 | -1.80 | 4.57 | 7.35 | -3.46 | 4.14 | 4.05 | 2.65 | 0.36 | 1.49 | 0.14 | 2.19 | -108.17 | 7.79 | 389.67 | -5.70 | -8.43 | 5.52 | 5.11 | -12.42 | 0.36 | -0.12 | -0.74 | 1.90 | NA | |
| Income Taxes Paid Net | -1.15 | 14.78 | -4.57 | -2.92 | -3.49 | 0.50 | 3.42 | -22.59 | 16.69 | -11.13 | 4.39 | -3.98 | -16.19 | 3.88 | 0.73 | -9.30 | 113.96 | -1.09 | -3.43 | -1.60 | 3.32 | -1.18 | 9.71 | 29.57 | 5.38 | 1.51 | -1.51 | 1.76 | 4.02 | NA | NA | |
| Profit Loss | 11.76 | 16.79 | -81.68 | -93.34 | 25.03 | 29.68 | -10.09 | -5.86 | -2.39 | -240.08 | -6.46 | -20.46 | -6.09 | 32.18 | 14.54 | -6.96 | -22.03 | -23.94 | 121.52 | -64.90 | -363.39 | -50.53 | -124.75 | -20.33 | 17.46 | -250.09 | 51.65 | 62.19 | 27.12 | 37.75 | 42.26 | |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | -34.52 | -0.17 | 15.54 | -37.25 | -5.29 | 8.31 | -14.27 | -3.27 | 32.64 | 14.07 | 53.62 | 18.24 | 2.71 | 0.70 | 20.77 | 3.75 | -1.60 | -9.77 | -62.66 | NA | NA | 0.00 | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Net Income Loss | -0.16 | 5.99 | -91.64 | -101.41 | 15.54 | 22.23 | -15.63 | -12.03 | -7.61 | -242.13 | -8.82 | -21.80 | -7.78 | 29.99 | 12.75 | -3.04 | -8.97 | -12.00 | 115.07 | -32.13 | -265.01 | -16.90 | -47.88 | -8.77 | 6.89 | -17.86 | NA | 0.00 | 0.00 | 0.00 | NA | |
| Comprehensive Income Net Of Tax | -43.50 | -0.73 | -83.00 | -135.55 | 5.46 | 16.23 | -13.18 | -6.93 | 8.98 | -119.59 | 22.43 | 2.03 | -3.47 | 14.97 | 13.81 | -3.04 | -10.57 | -18.27 | 81.73 | -26.85 | -262.82 | -19.55 | -44.20 | -6.63 | 3.57 | -20.27 | 0.00 | 0.00 | 0.00 | 0.00 | NA | |
| Net Income Loss Available To Common Stockholders Basic | -0.16 | 5.99 | -91.64 | -98.65 | 9.68 | 11.92 | -6.94 | -4.33 | -2.69 | -120.81 | -2.16 | -6.38 | -4.24 | 14.53 | 6.71 | -3.04 | -8.97 | -12.00 | 115.07 | -32.13 | -265.01 | -16.90 | -47.88 | -8.77 | 6.95 | -19.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 3460.98 | 3509.92 | 3456.40 | 3472.57 | 3687.08 | 3700.89 | 3626.61 | 3799.34 | 3874.04 | 4041.41 | 3888.97 | 3939.66 | 3974.41 | 4023.05 | 3960.07 | 4006.03 | 4037.54 | 4056.76 | 4390.80 | 3665.89 | 3703.94 | 4262.14 | 4384.59 | 4352.74 | 4582.05 | 4544.59 | 0.00 | 0.00 | NA | NA | NA | |
| Liabilities And Stockholders Equity | 3460.98 | 3509.92 | 3456.40 | 3472.57 | 3687.08 | 3700.89 | 3626.61 | 3799.34 | 3874.04 | 4041.41 | 3888.97 | 3939.66 | 3974.41 | 4023.05 | 3960.07 | 4006.03 | 4037.54 | 4056.76 | 4390.80 | 3665.89 | 3703.94 | 4262.14 | 4384.59 | 4352.74 | 4582.05 | 4544.59 | 0.00 | 0.00 | NA | NA | NA | |
| Stockholders Equity | -93.43 | -57.47 | -63.72 | 19.78 | 330.86 | 318.17 | 294.41 | 298.42 | 297.47 | 280.33 | 391.12 | 360.34 | 350.51 | 346.11 | 323.01 | 303.27 | 301.04 | 306.00 | 318.38 | 232.01 | 218.00 | 459.66 | 472.20 | 504.75 | NA | NA | 0.00 | 0.00 | NA | NA | NA |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets Current | 1513.29 | 1485.48 | 1380.04 | 1377.86 | 1456.08 | 1421.79 | 1307.33 | 1411.82 | 1419.83 | 1553.60 | 1389.68 | 1520.11 | 1570.34 | 1563.47 | 1559.66 | 1551.54 | 1543.72 | 1480.87 | 1773.70 | 1210.21 | 1205.83 | 1185.85 | 1267.97 | 1286.64 | 1431.30 | 1347.89 | 0.00 | 0.00 | NA | NA | NA | |
| Cash And Cash Equivalents At Carrying Value | 74.01 | 43.77 | 46.52 | 91.54 | 86.93 | 109.28 | 144.67 | 25.98 | 87.33 | 91.98 | 210.48 | 247.79 | 302.65 | 278.31 | 452.10 | 341.38 | 281.28 | 266.14 | 405.24 | 151.20 | 212.74 | 54.89 | 63.95 | 213.39 | 165.19 | 61.52 | 0.00 | 0.00 | 19.35 | 48.22 | NA | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 78.34 | 49.62 | 51.62 | 99.11 | 95.61 | 114.58 | 151.07 | 35.23 | 95.89 | 98.18 | 216.54 | 256.74 | 310.62 | 283.15 | 455.81 | 347.12 | 283.65 | 268.27 | 406.93 | 152.82 | 217.06 | 57.02 | 66.74 | 218.78 | 172.19 | 68.59 | 52.62 | 77.92 | 21.35 | 51.84 | NA | |
| Inventory Net | 596.36 | 575.62 | 570.65 | 581.38 | 576.47 | 550.56 | 529.04 | 530.74 | 543.86 | 533.03 | 512.24 | 489.39 | 520.25 | 523.38 | 497.01 | 490.65 | 475.76 | 443.96 | 437.96 | 381.07 | 401.83 | 414.63 | 448.29 | 457.22 | 490.77 | 512.48 | NA | 284.04 | NA | NA | NA | |
| Prepaid Expense And Other Assets Current | 81.96 | 81.60 | 87.30 | 82.69 | 91.44 | 81.76 | 81.42 | 103.56 | 149.65 | 232.20 | 121.41 | 110.22 | 110.21 | 103.80 | 75.14 | 73.47 | 76.26 | 184.75 | 204.41 | 70.16 | 66.70 | 77.06 | 111.56 | 128.32 | 126.39 | 139.60 | NA | 42.40 | NA | NA | NA |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amortization Of Intangible Assets | 43.30 | 40.10 | 39.90 | 40.70 | 40.60 | 40.80 | 41.10 | 44.62 | 44.55 | 41.98 | 40.92 | 43.70 | 43.81 | 43.52 | 41.67 | 43.87 | 44.55 | 43.98 | 42.58 | 40.18 | 38.02 | 34.80 | 30.96 | 28.88 | 25.66 | 16.69 | 1.76 | 0.92 | 1.28 | 0.89 | NA | |
| Property Plant And Equipment Net | 431.02 | 425.38 | 439.81 | 447.57 | 451.85 | 459.11 | 462.61 | 469.81 | 470.15 | 483.62 | 500.91 | 514.16 | 459.65 | 468.42 | 471.17 | 477.75 | 462.44 | 460.53 | 467.56 | 478.00 | 490.71 | 508.09 | 514.41 | 544.15 | 567.50 | 569.33 | NA | 486.76 | NA | NA | NA | |
| Goodwill | 598.32 | 598.53 | 598.55 | 598.63 | 598.63 | 599.21 | 599.16 | 598.85 | 599.50 | 600.97 | 602.89 | 593.02 | 566.41 | 549.09 | 522.76 | 522.81 | 522.69 | 527.48 | 514.73 | 419.50 | 419.67 | 420.02 | 421.64 | 426.23 | 410.62 | 386.48 | NA | 26.44 | NA | NA | NA | |
| Indefinite Lived Intangible Assets Excluding Goodwill | 14.30 | 355.85 | 355.85 | 355.85 | 387.86 | 390.36 | 390.36 | 390.75 | 405.43 | 405.43 | 405.43 | 405.43 | 405.52 | 422.99 | 379.39 | 379.39 | 381.12 | 381.12 | 381.12 | 382.07 | 382.52 | 428.78 | 429.14 | 451.93 | 565.87 | 571.25 | NA | 1.15 | NA | NA | NA | |
| Intangible Assets Net Excluding Goodwill | 780.19 | 819.94 | 859.27 | 890.42 | 982.53 | 1015.38 | 1055.32 | 1096.09 | 1159.01 | 1204.22 | 1209.82 | 1166.92 | 1232.73 | 1293.33 | 1262.95 | 1304.63 | 1349.11 | 1423.83 | 1475.16 | 1382.75 | 1435.80 | 1553.33 | 1591.16 | 1654.97 | 1733.02 | 1788.53 | NA | 44.60 | NA | NA | NA | |
| Finite Lived Intangible Assets Net | 765.89 | 464.10 | 503.43 | 534.58 | 594.68 | 625.02 | 664.96 | 705.34 | 753.58 | 798.80 | 804.39 | 761.50 | 827.20 | 870.34 | 883.56 | 925.23 | 968.00 | 1042.71 | 1094.05 | 1000.68 | 1053.28 | 1124.55 | 1162.02 | 1203.04 | 1167.15 | 1217.28 | NA | 43.45 | NA | NA | NA | |
| Other Assets Noncurrent | 36.27 | 77.03 | 73.75 | 55.52 | 89.04 | 93.24 | 86.43 | 103.22 | 108.26 | 79.84 | 63.94 | 20.61 | 19.53 | 19.22 | 19.56 | 31.89 | 31.14 | 28.73 | 26.46 | 44.27 | 18.61 | 63.46 | 62.42 | 67.59 | 73.64 | 78.65 | NA | 11.26 | NA | NA | NA |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Current | 1095.21 | 1114.35 | 834.39 | 846.60 | 760.60 | 777.35 | 703.71 | 752.80 | 818.00 | 993.06 | 602.04 | 677.24 | 667.34 | 672.86 | 636.78 | 676.90 | 667.89 | 655.02 | 965.07 | 550.41 | 534.91 | 546.16 | 599.53 | 553.85 | 749.27 | 669.74 | 0.00 | 0.00 | NA | NA | NA | |
| Long Term Debt Current | 224.69 | 225.16 | 33.66 | 34.12 | 30.53 | 30.41 | 29.96 | 29.96 | 29.94 | 29.92 | 30.52 | 30.61 | 30.47 | 30.46 | 29.82 | 44.23 | 29.78 | 29.76 | 29.74 | 21.48 | NA | NA | NA | 21.45 | NA | NA | NA | 89.17 | NA | NA | NA | |
| Accounts Payable Current | 235.00 | 199.58 | 175.32 | 143.57 | 177.40 | 139.53 | 136.92 | 165.98 | NA | NA | NA | 131.08 | NA | NA | NA | 153.14 | NA | NA | NA | 103.02 | NA | NA | NA | 114.85 | 124.54 | 169.05 | NA | 70.01 | NA | NA | NA | |
| Other Accrued Liabilities Current | 54.13 | 55.58 | 59.97 | 48.22 | 55.45 | 44.47 | 44.45 | 45.81 | NA | NA | NA | 40.88 | NA | NA | NA | 46.93 | NA | NA | NA | 35.90 | NA | NA | NA | 37.35 | 30.50 | 35.18 | NA | 23.82 | NA | NA | NA |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Noncurrent | 2399.45 | 2399.64 | 2638.62 | 2564.67 | 2735.10 | 2740.66 | 2760.70 | 2837.61 | 2839.38 | 2857.47 | 2863.10 | 2878.54 | 2908.65 | 2945.81 | 2943.50 | 2972.39 | 3009.52 | 3018.34 | 3009.71 | 2768.70 | 2773.31 | 2966.63 | 2985.28 | 2902.52 | 2917.46 | 2923.51 | NA | 1420.59 | NA | NA | NA | |
| Long Term Debt | 2394.30 | 2402.73 | 2411.37 | 2420.13 | 2572.35 | 2579.58 | 2591.69 | 2621.94 | 2637.16 | 2652.37 | NA | 2710.67 | NA | NA | NA | 2779.49 | 2786.91 | 2794.33 | 2801.76 | 2630.53 | NA | NA | NA | 2652.05 | NA | 2662.73 | NA | 1444.44 | NA | NA | NA | |
| Long Term Debt Noncurrent | 2169.61 | 2177.58 | 2377.71 | 2386.00 | 2541.81 | 2549.18 | 2561.72 | 2591.98 | 2607.22 | 2622.45 | 2672.66 | 2680.05 | 2687.67 | 2720.12 | 2728.21 | 2735.26 | 2757.14 | 2764.58 | 2772.03 | 2609.05 | 2614.41 | 2619.79 | 2625.15 | 2630.60 | NA | 2641.30 | NA | 1355.27 | NA | NA | NA | |
| Minority Interest | -0.14 | -0.02 | 0.10 | 0.23 | -176.62 | -167.40 | -159.75 | -114.44 | -103.18 | -107.34 | 16.28 | 6.63 | 32.66 | 44.16 | 43.69 | 41.66 | 47.16 | 65.02 | 85.08 | 114.78 | 177.72 | 289.70 | 327.58 | 391.61 | NA | NA | NA | NA | NA | NA | NA |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -93.43 | -57.47 | -63.72 | 19.78 | 330.86 | 318.17 | 294.41 | 298.42 | 297.47 | 280.33 | 391.12 | 360.34 | 350.51 | 346.11 | 323.01 | 303.27 | 301.04 | 306.00 | 318.38 | 232.01 | 218.00 | 459.66 | 472.20 | 504.75 | NA | NA | 0.00 | 0.00 | NA | NA | NA | |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -93.57 | -57.49 | -63.63 | 20.01 | 154.24 | 150.77 | 134.67 | 183.98 | 194.29 | 172.99 | 407.41 | 366.97 | 383.17 | 390.27 | 366.71 | 344.93 | 348.20 | 371.02 | 403.46 | 346.79 | 395.72 | 749.35 | 799.78 | 896.36 | 915.32 | 939.49 | NA | 0.00 | NA | NA | NA | |
| Additional Paid In Capital | 553.23 | 545.70 | 538.72 | 539.24 | 715.45 | 708.23 | 700.72 | 691.63 | 683.75 | 675.59 | 666.80 | 658.35 | 650.54 | 642.66 | 634.48 | 628.41 | 623.13 | 617.50 | 611.60 | 606.97 | 565.64 | 544.16 | 537.16 | 530.44 | 520.16 | 517.12 | NA | 8.56 | NA | NA | NA | |
| Retained Earnings Accumulated Deficit | -575.98 | -575.83 | -581.82 | -490.18 | -391.53 | -401.21 | -413.13 | -406.18 | -401.85 | -399.16 | -278.35 | -276.20 | -269.82 | -265.58 | -280.12 | -286.82 | -283.78 | -274.81 | -262.81 | -377.88 | -345.75 | -80.75 | -63.84 | -20.92 | -12.15 | -19.10 | NA | -382.79 | NA | NA | NA | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -73.78 | -30.44 | -23.71 | -32.35 | 3.87 | 8.08 | 3.76 | 9.94 | 12.54 | 0.87 | -0.35 | -24.83 | -33.23 | -33.98 | -34.36 | -41.32 | -41.31 | -39.70 | -33.41 | -0.07 | -4.88 | -6.75 | -4.10 | -7.75 | -9.89 | -6.50 | NA | -14.23 | NA | NA | NA | |
| Minority Interest | -0.14 | -0.02 | 0.10 | 0.23 | -176.62 | -167.40 | -159.75 | -114.44 | -103.18 | -107.34 | 16.28 | 6.63 | 32.66 | 44.16 | 43.69 | 41.66 | 47.16 | 65.02 | 85.08 | 114.78 | 177.72 | 289.70 | 327.58 | 391.61 | NA | NA | NA | NA | NA | NA | NA | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 7.11 | 6.72 | 6.72 | 5.97 | 6.69 | 6.56 | 7.60 | 7.83 | 7.69 | 8.26 | 8.06 | 7.74 | 7.71 | 7.63 | 5.33 | 5.13 | 5.42 | 5.66 | 4.54 | 5.01 | 6.09 | 6.22 | 4.35 | 3.61 | 3.59 | 1.64 | NA | NA | NA | NA | NA |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | 141.77 | 39.66 | -4.41 | 135.82 | 81.39 | -11.35 | 139.71 | -23.29 | 93.57 | -125.52 | 120.34 | 63.26 | 82.36 | -51.93 | 148.13 | 105.96 | 44.78 | 179.24 | 49.03 | -50.89 | 139.91 | 21.09 | -108.41 | 259.65 | 62.13 | -98.58 | 27.03 | 65.27 | 73.51 | NA | NA | |
| Net Cash Provided By Used In Investing Activities | -20.71 | -6.46 | -19.76 | -31.69 | -13.48 | -12.28 | -11.74 | -11.47 | -49.33 | -16.12 | -97.39 | -86.97 | -11.63 | -82.89 | -12.69 | -31.80 | -14.78 | -8.93 | -262.04 | -4.77 | 29.98 | -23.33 | -21.47 | 5.32 | -40.77 | -341.43 | -19.50 | -8.90 | -35.04 | NA | NA | |
| Net Cash Provided By Used In Financing Activities | -92.35 | -35.09 | -23.16 | -100.83 | -86.58 | -12.26 | -12.90 | -22.17 | -46.13 | 23.25 | -61.57 | -30.35 | -43.55 | -38.07 | -26.15 | -11.28 | -14.81 | -310.08 | 467.98 | -7.30 | -7.60 | -9.07 | -21.86 | -218.92 | 82.60 | 457.24 | -33.25 | 0.50 | -63.77 | NA | NA |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | 141.77 | 39.66 | -4.41 | 135.82 | 81.39 | -11.35 | 139.71 | -23.29 | 93.57 | -125.52 | 120.34 | 63.26 | 82.36 | -51.93 | 148.13 | 105.96 | 44.78 | 179.24 | 49.03 | -50.89 | 139.91 | 21.09 | -108.41 | 259.65 | 62.13 | -98.58 | 27.03 | 65.27 | 73.51 | NA | NA | |
| Net Income Loss | -0.16 | 5.99 | -91.64 | -101.41 | 15.54 | 22.23 | -15.63 | -12.03 | -7.61 | -242.13 | -8.82 | -21.80 | -7.78 | 29.99 | 12.75 | -3.04 | -8.97 | -12.00 | 115.07 | -32.13 | -265.01 | -16.90 | -47.88 | -8.77 | 6.89 | -17.86 | NA | 0.00 | 0.00 | 0.00 | NA | |
| Profit Loss | 11.76 | 16.79 | -81.68 | -93.34 | 25.03 | 29.68 | -10.09 | -5.86 | -2.39 | -240.08 | -6.46 | -20.46 | -6.09 | 32.18 | 14.54 | -6.96 | -22.03 | -23.94 | 121.52 | -64.90 | -363.39 | -50.53 | -124.75 | -20.33 | 17.46 | -250.09 | 51.65 | 62.19 | 27.12 | 37.75 | 42.26 | |
| Increase Decrease In Accounts Receivable | -21.81 | 100.67 | 55.17 | -77.23 | 17.92 | 128.99 | -195.97 | 113.29 | -60.13 | 150.83 | -124.27 | 34.52 | -24.06 | 121.55 | -108.39 | -67.53 | 126.52 | -136.66 | 60.89 | 86.27 | -116.50 | -2.06 | 165.01 | -163.79 | 14.66 | 65.03 | -4.98 | 13.21 | -20.40 | NA | NA | |
| Increase Decrease In Inventories | 43.10 | 23.25 | 12.20 | 23.09 | 42.57 | 38.02 | 22.51 | 11.07 | 25.93 | 39.85 | 25.55 | -16.63 | 11.06 | 34.30 | 20.28 | 33.06 | 47.54 | 30.40 | 2.78 | -5.51 | 6.25 | 5.48 | 14.18 | -10.83 | -17.95 | 24.07 | 47.59 | 6.64 | 14.30 | NA | NA | |
| Share Based Compensation | 7.11 | 6.72 | 6.72 | 5.97 | 6.69 | 6.56 | 7.60 | 7.83 | 7.69 | 8.26 | 8.06 | 7.74 | 7.71 | 7.63 | 5.33 | 5.13 | 5.42 | 5.66 | 4.54 | 5.01 | 6.09 | 6.22 | 4.35 | 3.61 | 3.59 | 160.40 | 0.00 | 0.00 | 0.00 | NA | NA |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | -20.71 | -6.46 | -19.76 | -31.69 | -13.48 | -12.28 | -11.74 | -11.47 | -49.33 | -16.12 | -97.39 | -86.97 | -11.63 | -82.89 | -12.69 | -31.80 | -14.78 | -8.93 | -262.04 | -4.77 | 29.98 | -23.33 | -21.47 | 5.32 | -40.77 | -341.43 | -19.50 | -8.90 | -35.04 | NA | NA | |
| Payments To Acquire Property Plant And Equipment | 16.95 | 10.63 | 9.20 | 9.87 | 11.66 | 12.00 | 9.69 | 11.47 | 19.10 | 5.05 | 10.79 | 17.50 | 10.64 | 7.81 | 11.78 | 29.53 | 10.99 | 8.55 | 7.37 | 4.52 | 13.04 | 11.64 | 17.99 | 20.02 | 26.46 | 17.10 | 19.50 | 24.62 | 15.54 | NA | NA |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | -92.35 | -35.09 | -23.16 | -100.83 | -86.58 | -12.26 | -12.90 | -22.17 | -46.13 | 23.25 | -61.57 | -30.35 | -43.55 | -38.07 | -26.15 | -11.28 | -14.81 | -310.08 | 467.98 | -7.30 | -7.60 | -9.07 | -21.86 | -218.92 | 82.60 | 457.24 | -33.25 | 0.50 | -63.77 | NA | NA |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 702.47 | 701.78 | 659.19 | 616.98 | 620.04 | 599.05 | 557.54 | 609.76 | 545.56 | 559.36 | 497.63 | 536.90 | 528.59 | 535.08 | 493.11 | 510.03 | 519.29 | 464.66 | 498.53 | 397.33 | 378.28 | 404.64 | 446.12 | 497.53 | 476.49 | 413.79 | 275.19 | 293.37 | 254.73 | 259.87 | 225.68 | |
| Operating, Amneal Specialty Pharma | 115.64 | 104.04 | 105.23 | NA | 97.30 | 96.99 | 91.68 | 102.55 | 89.48 | 97.00 | 85.09 | 101.01 | 92.75 | 88.64 | 95.93 | 85.47 | 87.87 | 94.26 | 87.98 | 97.05 | 87.26 | 69.58 | 63.64 | 86.63 | 85.31 | 52.02 | 0.00 | NA | 0.00 | NA | NA | |
| Operating, Av K A R E | 159.49 | 170.41 | 162.66 | 149.46 | 131.88 | 128.35 | 122.06 | 108.04 | 105.81 | 97.46 | 94.80 | 89.62 | 88.72 | 86.00 | 84.67 | 82.42 | 89.51 | 63.85 | 57.97 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Operating, Generics | 427.35 | 427.33 | 391.29 | 363.04 | 390.86 | 373.70 | 343.81 | 399.17 | 350.27 | 364.89 | 317.75 | 346.27 | 347.13 | 360.44 | 312.51 | 342.14 | 341.92 | 306.56 | 352.59 | 300.28 | 291.02 | 335.06 | 382.48 | 410.90 | 391.18 | 361.77 | 275.19 | NA | NA | NA | NA | |
| Anti Infective,US, Generics | 5.45 | 6.40 | 6.11 | 7.24 | 7.38 | 6.09 | 5.17 | 6.42 | 4.96 | 5.57 | 6.25 | 5.50 | 9.41 | 9.68 | 5.91 | 7.79 | 9.81 | 9.72 | 13.25 | 12.32 | 9.91 | 8.15 | 5.94 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Antiviral,US, Generics | 4.37 | 4.31 | 3.87 | 3.69 | 7.15 | 3.60 | 25.47 | 22.95 | 5.78 | 1.30 | 10.57 | 3.27 | 9.76 | -0.26 | -7.94 | -0.29 | 9.24 | 0.95 | 15.82 | 8.11 | 3.57 | 1.35 | 14.46 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Cardiovascular System,US, Generics | 36.42 | 41.33 | 45.88 | 41.83 | 32.46 | 33.15 | 32.50 | 33.76 | 28.93 | 32.04 | 23.45 | 34.73 | 35.69 | 36.13 | 35.31 | 31.35 | 28.52 | 25.11 | 29.68 | 23.47 | 26.24 | 31.14 | 36.22 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Central Nervous System,US, Generics | 108.96 | 121.77 | 109.46 | 104.43 | 96.59 | 83.60 | 84.58 | 106.49 | 96.88 | 108.79 | 81.12 | 86.93 | 91.26 | 106.63 | 96.29 | 119.46 | 107.14 | 96.23 | 101.58 | 87.42 | 93.82 | 117.40 | 124.78 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Central Nervous System,US, Specialty | 73.40 | 63.91 | 66.28 | 69.14 | 61.14 | 59.56 | 60.14 | 70.35 | 61.78 | 65.36 | 58.17 | 75.49 | 68.87 | 65.13 | 67.71 | 75.31 | 68.06 | 74.06 | 68.31 | 74.81 | 67.45 | 50.69 | 42.90 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Dermatology,US, Generics | 19.28 | 20.57 | 18.98 | 17.64 | 17.28 | 17.95 | 18.00 | 17.81 | 17.33 | 17.94 | 13.48 | 12.92 | 14.86 | 14.82 | 12.88 | 15.77 | 14.82 | 10.44 | 15.24 | 16.68 | 15.77 | 14.77 | 12.97 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Gastroenterology,US, Generics | 14.47 | 12.73 | 18.20 | 14.39 | 18.86 | 19.91 | 14.36 | 19.52 | 17.13 | 17.53 | 16.62 | 20.16 | 17.17 | 19.70 | 19.46 | 18.92 | 21.37 | 16.62 | 23.54 | 14.21 | 9.08 | 9.94 | 9.56 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Government Label,US, Av K A R E | 41.94 | 36.21 | 34.95 | 34.68 | 32.76 | 29.87 | 24.52 | 25.50 | 26.00 | 22.28 | 24.46 | 28.24 | 29.90 | 29.17 | 31.07 | 28.70 | 28.90 | 25.07 | 21.38 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Hormonal Allergy,US, Generics | 132.64 | 123.57 | 107.71 | 94.03 | 126.42 | 126.44 | 104.85 | 110.51 | 119.73 | 118.31 | 96.37 | 101.11 | 107.61 | 111.65 | 106.70 | 84.08 | 93.58 | 89.28 | 87.48 | 84.39 | 85.25 | 92.29 | 102.72 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Hormonal Allergy,US, Specialty | 32.28 | 31.77 | 29.38 | 28.22 | 28.49 | 29.01 | 24.76 | 25.71 | 22.01 | 24.32 | 19.42 | 19.17 | 16.42 | 16.01 | 16.80 | 13.97 | 13.04 | 13.67 | 13.95 | 13.24 | 11.52 | 9.89 | 10.90 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Institutional,US, Av K A R E | 9.39 | 11.77 | 10.86 | 9.62 | 10.55 | 8.98 | 8.86 | 7.07 | 8.30 | 6.06 | 6.32 | 6.34 | 7.87 | 5.78 | 5.18 | 5.73 | 4.89 | 4.51 | 3.41 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| License Agreement,US, Specialty | 2.05 | 0.00 | 4.48 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Metabolic Disease Endocrine,US, Generics | 8.64 | 9.47 | 11.19 | 10.67 | 11.03 | 14.94 | 9.27 | 10.63 | 9.28 | 9.99 | 11.23 | 12.13 | 12.89 | 6.88 | 6.56 | 11.61 | 9.99 | 6.77 | 17.23 | 14.48 | 12.57 | 10.89 | 17.85 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Oncology,US, Generics | 44.47 | 48.27 | 38.53 | 33.61 | 37.72 | 28.55 | 10.58 | 16.41 | 12.24 | 18.42 | 17.21 | 29.64 | 21.20 | 33.45 | 19.03 | 15.76 | 13.93 | 16.57 | 15.97 | 9.74 | 16.27 | 21.75 | 14.96 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Other Therapeutic Classes,US, Generics | 38.67 | 24.07 | 18.52 | 24.13 | 27.27 | 27.81 | 25.89 | 31.78 | 29.10 | 22.33 | 35.36 | 30.07 | 18.98 | 11.14 | 9.73 | 28.13 | 22.66 | 26.67 | 21.75 | NA | 10.13 | 15.26 | 18.18 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Other Therapeutic Classes,US, Specialty | 7.91 | 8.36 | 5.10 | 7.13 | 7.67 | 8.42 | 6.78 | 6.49 | 5.69 | 6.84 | 7.43 | 6.36 | 7.45 | 7.49 | 11.42 | -1.71 | 5.63 | 5.89 | 5.39 | NA | 7.76 | 8.46 | 8.82 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Respiratory,US, Generics | 9.46 | 13.41 | 11.14 | 10.93 | 7.83 | 11.14 | 12.81 | 14.58 | 8.72 | 12.12 | 5.67 | 9.09 | 8.23 | 10.46 | 8.18 | 9.19 | 10.88 | 7.24 | 10.07 | 9.51 | 7.77 | 8.42 | 9.22 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Distribution Service,US, Av K A R E | 101.61 | 116.14 | 109.71 | 98.48 | 81.90 | 83.80 | 83.23 | 70.00 | 66.06 | 64.24 | 60.26 | 51.06 | 48.05 | 48.32 | 45.50 | 44.85 | 53.40 | 31.84 | 31.59 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Product And Service Other,US, Av K A R E | 6.55 | 6.30 | 7.14 | 6.69 | 6.66 | 5.70 | 5.45 | 5.48 | 5.45 | 4.88 | 3.76 | 3.98 | 2.90 | 2.73 | 2.92 | 3.14 | 2.31 | 2.42 | 1.59 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Av K A R E | 159.49 | 170.41 | 162.66 | 149.46 | 131.88 | 128.35 | 122.06 | 108.04 | 105.81 | 97.46 | 94.80 | 89.62 | 88.72 | 86.00 | 84.67 | 82.42 | 89.51 | 63.85 | 57.97 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Generics | 427.35 | 427.33 | 391.29 | 363.04 | 390.86 | 373.70 | 343.81 | 399.17 | 350.27 | 364.89 | 317.75 | 346.27 | 347.13 | 360.44 | 312.51 | 342.14 | 341.92 | 306.56 | 352.59 | 300.28 | 291.02 | 335.06 | 382.48 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Specialty | 115.64 | 104.04 | 105.23 | 104.48 | 97.30 | 96.99 | 91.68 | 102.55 | 89.48 | 97.00 | 85.09 | 101.01 | 92.75 | 88.64 | 95.93 | 85.47 | 87.87 | 94.26 | 87.98 | 97.05 | 87.26 | 69.58 | 63.64 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Non Us, Generics | 4.51 | 1.43 | 1.72 | 0.45 | 0.87 | 0.55 | 0.30 | 0.27 | 0.20 | 0.57 | 0.42 | 0.71 | 0.05 | 0.15 | 0.40 | 0.39 | 0.00 | 0.96 | 0.98 | 0.61 | 0.64 | 3.72 | 15.63 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Revenue From Contract With Customer Excluding Assessed Tax | 702.47 | 701.78 | 659.19 | 616.98 | 620.04 | 599.05 | 557.54 | 609.76 | 545.56 | 559.36 | 497.63 | 536.90 | 528.59 | 535.08 | 493.11 | 510.03 | 519.29 | 464.66 | 498.53 | 397.33 | 378.28 | 404.64 | 446.12 | 497.53 | 476.49 | 413.79 | 275.19 | 293.37 | 254.73 | 259.87 | 225.68 | |
| Operating, Amneal Specialty Pharma | 115.64 | 104.04 | 105.23 | NA | 97.30 | 96.99 | 91.68 | 102.55 | 89.48 | 97.00 | 85.09 | 101.01 | 92.75 | 88.64 | 95.93 | 85.47 | 87.87 | 94.26 | 87.98 | 97.05 | 87.26 | 69.58 | 63.64 | 86.63 | 85.31 | 52.02 | 0.00 | NA | 0.00 | NA | NA | |
| Operating, Av K A R E | 159.49 | 170.41 | 162.66 | 149.46 | 131.88 | 128.35 | 122.06 | 108.04 | 105.81 | 97.46 | 94.80 | 89.62 | 88.72 | 86.00 | 84.67 | 82.42 | 89.51 | 63.85 | 57.97 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Operating, Generics | 427.35 | 427.33 | 391.29 | 363.04 | 390.86 | 373.70 | 343.81 | 399.17 | 350.27 | 364.89 | 317.75 | 346.27 | 347.13 | 360.44 | 312.51 | 342.14 | 341.92 | 306.56 | 352.59 | 300.28 | 291.02 | 335.06 | 382.48 | 410.90 | 391.18 | 361.77 | 275.19 | NA | NA | NA | NA | |
| Anti Infective,US, Generics | 5.45 | 6.40 | 6.11 | 7.24 | 7.38 | 6.09 | 5.17 | 6.42 | 4.96 | 5.57 | 6.25 | 5.50 | 9.41 | 9.68 | 5.91 | 7.79 | 9.81 | 9.72 | 13.25 | 12.32 | 9.91 | 8.15 | 5.94 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Antiviral,US, Generics | 4.37 | 4.31 | 3.87 | 3.69 | 7.15 | 3.60 | 25.47 | 22.95 | 5.78 | 1.30 | 10.57 | 3.27 | 9.76 | -0.26 | -7.94 | -0.29 | 9.24 | 0.95 | 15.82 | 8.11 | 3.57 | 1.35 | 14.46 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Cardiovascular System,US, Generics | 36.42 | 41.33 | 45.88 | 41.83 | 32.46 | 33.15 | 32.50 | 33.76 | 28.93 | 32.04 | 23.45 | 34.73 | 35.69 | 36.13 | 35.31 | 31.35 | 28.52 | 25.11 | 29.68 | 23.47 | 26.24 | 31.14 | 36.22 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Central Nervous System,US, Generics | 108.96 | 121.77 | 109.46 | 104.43 | 96.59 | 83.60 | 84.58 | 106.49 | 96.88 | 108.79 | 81.12 | 86.93 | 91.26 | 106.63 | 96.29 | 119.46 | 107.14 | 96.23 | 101.58 | 87.42 | 93.82 | 117.40 | 124.78 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Central Nervous System,US, Specialty | 73.40 | 63.91 | 66.28 | 69.14 | 61.14 | 59.56 | 60.14 | 70.35 | 61.78 | 65.36 | 58.17 | 75.49 | 68.87 | 65.13 | 67.71 | 75.31 | 68.06 | 74.06 | 68.31 | 74.81 | 67.45 | 50.69 | 42.90 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Dermatology,US, Generics | 19.28 | 20.57 | 18.98 | 17.64 | 17.28 | 17.95 | 18.00 | 17.81 | 17.33 | 17.94 | 13.48 | 12.92 | 14.86 | 14.82 | 12.88 | 15.77 | 14.82 | 10.44 | 15.24 | 16.68 | 15.77 | 14.77 | 12.97 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Gastroenterology,US, Generics | 14.47 | 12.73 | 18.20 | 14.39 | 18.86 | 19.91 | 14.36 | 19.52 | 17.13 | 17.53 | 16.62 | 20.16 | 17.17 | 19.70 | 19.46 | 18.92 | 21.37 | 16.62 | 23.54 | 14.21 | 9.08 | 9.94 | 9.56 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Government Label,US, Av K A R E | 41.94 | 36.21 | 34.95 | 34.68 | 32.76 | 29.87 | 24.52 | 25.50 | 26.00 | 22.28 | 24.46 | 28.24 | 29.90 | 29.17 | 31.07 | 28.70 | 28.90 | 25.07 | 21.38 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Hormonal Allergy,US, Generics | 132.64 | 123.57 | 107.71 | 94.03 | 126.42 | 126.44 | 104.85 | 110.51 | 119.73 | 118.31 | 96.37 | 101.11 | 107.61 | 111.65 | 106.70 | 84.08 | 93.58 | 89.28 | 87.48 | 84.39 | 85.25 | 92.29 | 102.72 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Hormonal Allergy,US, Specialty | 32.28 | 31.77 | 29.38 | 28.22 | 28.49 | 29.01 | 24.76 | 25.71 | 22.01 | 24.32 | 19.42 | 19.17 | 16.42 | 16.01 | 16.80 | 13.97 | 13.04 | 13.67 | 13.95 | 13.24 | 11.52 | 9.89 | 10.90 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Institutional,US, Av K A R E | 9.39 | 11.77 | 10.86 | 9.62 | 10.55 | 8.98 | 8.86 | 7.07 | 8.30 | 6.06 | 6.32 | 6.34 | 7.87 | 5.78 | 5.18 | 5.73 | 4.89 | 4.51 | 3.41 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| License Agreement,US, Specialty | 2.05 | 0.00 | 4.48 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Metabolic Disease Endocrine,US, Generics | 8.64 | 9.47 | 11.19 | 10.67 | 11.03 | 14.94 | 9.27 | 10.63 | 9.28 | 9.99 | 11.23 | 12.13 | 12.89 | 6.88 | 6.56 | 11.61 | 9.99 | 6.77 | 17.23 | 14.48 | 12.57 | 10.89 | 17.85 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Oncology,US, Generics | 44.47 | 48.27 | 38.53 | 33.61 | 37.72 | 28.55 | 10.58 | 16.41 | 12.24 | 18.42 | 17.21 | 29.64 | 21.20 | 33.45 | 19.03 | 15.76 | 13.93 | 16.57 | 15.97 | 9.74 | 16.27 | 21.75 | 14.96 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Other Therapeutic Classes,US, Generics | 38.67 | 24.07 | 18.52 | 24.13 | 27.27 | 27.81 | 25.89 | 31.78 | 29.10 | 22.33 | 35.36 | 30.07 | 18.98 | 11.14 | 9.73 | 28.13 | 22.66 | 26.67 | 21.75 | NA | 10.13 | 15.26 | 18.18 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Other Therapeutic Classes,US, Specialty | 7.91 | 8.36 | 5.10 | 7.13 | 7.67 | 8.42 | 6.78 | 6.49 | 5.69 | 6.84 | 7.43 | 6.36 | 7.45 | 7.49 | 11.42 | -1.71 | 5.63 | 5.89 | 5.39 | NA | 7.76 | 8.46 | 8.82 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Respiratory,US, Generics | 9.46 | 13.41 | 11.14 | 10.93 | 7.83 | 11.14 | 12.81 | 14.58 | 8.72 | 12.12 | 5.67 | 9.09 | 8.23 | 10.46 | 8.18 | 9.19 | 10.88 | 7.24 | 10.07 | 9.51 | 7.77 | 8.42 | 9.22 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Distribution Service,US, Av K A R E | 101.61 | 116.14 | 109.71 | 98.48 | 81.90 | 83.80 | 83.23 | 70.00 | 66.06 | 64.24 | 60.26 | 51.06 | 48.05 | 48.32 | 45.50 | 44.85 | 53.40 | 31.84 | 31.59 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Product And Service Other,US, Av K A R E | 6.55 | 6.30 | 7.14 | 6.69 | 6.66 | 5.70 | 5.45 | 5.48 | 5.45 | 4.88 | 3.76 | 3.98 | 2.90 | 2.73 | 2.92 | 3.14 | 2.31 | 2.42 | 1.59 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Av K A R E | 159.49 | 170.41 | 162.66 | 149.46 | 131.88 | 128.35 | 122.06 | 108.04 | 105.81 | 97.46 | 94.80 | 89.62 | 88.72 | 86.00 | 84.67 | 82.42 | 89.51 | 63.85 | 57.97 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Generics | 427.35 | 427.33 | 391.29 | 363.04 | 390.86 | 373.70 | 343.81 | 399.17 | 350.27 | 364.89 | 317.75 | 346.27 | 347.13 | 360.44 | 312.51 | 342.14 | 341.92 | 306.56 | 352.59 | 300.28 | 291.02 | 335.06 | 382.48 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Specialty | 115.64 | 104.04 | 105.23 | 104.48 | 97.30 | 96.99 | 91.68 | 102.55 | 89.48 | 97.00 | 85.09 | 101.01 | 92.75 | 88.64 | 95.93 | 85.47 | 87.87 | 94.26 | 87.98 | 97.05 | 87.26 | 69.58 | 63.64 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Non Us, Generics | 4.51 | 1.43 | 1.72 | 0.45 | 0.87 | 0.55 | 0.30 | 0.27 | 0.20 | 0.57 | 0.42 | 0.71 | 0.05 | 0.15 | 0.40 | 0.39 | 0.00 | 0.96 | 0.98 | 0.61 | 0.64 | 3.72 | 15.63 | NA | NA | NA | NA | NA | NA | NA | NA |
